首页> 美国卫生研究院文献>Journal of Clinical Oncology >Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Childrens Oncology Group

【2h】

Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Childrens Oncology Group

机译：组间横纹肌肉瘤研究组D9602方案的结果使用长春新碱和放线菌素联合或不联合环磷酰胺和放射疗法对新诊断的低风险胚胎性横纹肌肉瘤患者：儿童肿瘤学组软组织肉瘤委员会的报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposePatients with localized, grossly resected, or gross residual (orbital only) embryonal rhabdomyosarcoma (ERMS) had 5-year failure-free survival (FFS) rates of 83% and overall survival rates of 95% on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III/IV. IRSG D9602 protocol (1997 to 2004) objectives were to decrease toxicity in similar patients by reducing radiotherapy (RT) doses and eliminating cyclophosphamide for the lowest-risk patients.

机译：目的根据组间横纹肌肉瘤研究组（IRSG）协议，具有局部，大体切除或大残留（仅眼眶）胚胎性横纹肌肉瘤（ERMS）的患者的5年无衰竭生存率（FFS）为83％，总生存率为95％ III / IV。 IRSG D9602协议（1997年至2004年）的目标是通过降低放射治疗（RT）剂量并消除风险最低的患者的环磷酰胺来降低类似患者的毒性。

著录项

期刊名称 Journal of Clinical Oncology
作者
R. Beverly Raney; David O. Walterhouse; Jane L. Meza; Richard J. Andrassy; John C. Breneman; William M. Crist; Harold M. Maurer; William H. Meyer; David M. Parham; James R. Anderson;
展开▼
作者单位

展开▼
年(卷),期 -1(29),10
年度 -1
页码 1312–1318
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. [J] . Beverly Raney R, Walterhouse DO, Meza JL, Journal of Clinical Oncology . 2011,第10期

机译：组间性横纹肌肉瘤研究组D9602方案的结果，使用长春新碱和放线菌素联合或不联合环磷酰胺和放疗，适用于新诊断的低危胚胎性横纹肌肉瘤患者：儿童肿瘤学组软组织肉瘤委员会的报告。
2. Shorter-Duration Therapy Using Vincristine, Dactinomycin, and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group (vol 32, pg 3547, 2014) [J] . Walterhouse D. O., Pappo A. S., Meza J. L., Journal of Clinical Oncology . 2018,第14期

机译：使用长春霉素，丁霉素和低剂量环磷酰胺的较短持续时间治疗，用于新诊断的低风险rhabdomyosarcoma的患者：来自儿童肿瘤组软组织萨拉科委员会的报告（Vol 32，PG 3547,2014）
3. Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the Children's Oncology Group [J] . WalterhouseD.O., PappoA.S., MezaJ.L., Journal of Clinical Oncology . 2014,第31期

机译：长春新碱，放线菌素和低剂量环磷酰胺联合放疗或不联合放疗的短期治疗，用于新诊断的低危横纹肌肉瘤患者：儿童肿瘤学组软组织肉瘤委员会的报告
4. Shorter-Duration Therapy Using Vincristine Dactinomycin and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Childrens Oncology Group [O] . David O. Walterhouse, Alberto S. Pappo, Jane L. Meza, -1

机译：长春新碱放线菌素和小剂量环磷酰胺联合或不联合放疗的短期治疗用于新诊断的低风险横纹肌肉瘤患者：儿童肿瘤学组软组织肉瘤委员会的报告
5. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group [O] . Beverly Raney, R., Walterhouse, David O., Meza, Jane L., 2011

机译：组间横纹肌肉瘤研究组D9602方案的结果，使用长春新碱和放线菌素联合或不联合环磷酰胺和放射疗法，对新诊断的低风险胚胎性横纹肌肉瘤患者：儿童肿瘤学组软组织肉瘤委员会的报告

摘要

著录项

相似文献

相关主题

期刊订阅